Cleared Traditional

K870968 - TOTAL T3-RIA KIT COATED TUBE RADIOIMMUNOASSAY KIT

K870968 is an FDA 510(k) clearance for TOTAL T3-RIA KIT COATED TUBE RADIOIMMUN..., manufactured by Canadian Bioclinical, Ltd.. The device is a Class 2 Chemistry device with product code CDP cleared through the Traditional 510(k) pathway after a 104-day FDA review.

K870968 · Canadian Bioclinical, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1987
Decision
104d
Days
Class 2
Risk

K870968 is an FDA 510(k) clearance for the TOTAL T3-RIA KIT COATED TUBE RADIOIMMUNOASSAY KIT. Classified as Radioimmunoassay, Total Triiodothyronine (product code CDP), Class II - Special Controls.

Submitted by Canadian Bioclinical, Ltd. (Ontario Mix 1b4, CA). The FDA issued a Cleared decision on June 22, 1987 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1710 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Canadian Bioclinical, Ltd. devices

FDA 510(k) Submission Details - K870968

510(k) Number K870968 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 1987
Decision Date June 22, 1987
Days to Decision 104 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 88d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CDP Device Classification - Class 2, Special Controls

Product Code CDP Radioimmunoassay, Total Triiodothyronine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1710
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CDP Radioimmunoassay, Total Triiodothyronine

All 119
Devices cleared under the same product code (CDP) and FDA review panel - the closest regulatory comparables to K870968.
CIBA CORNING MAGIC LITE T3 IMMUNOASSAY
K873945 · Ciba Corning Diagnostics Corp. · Nov 1987
AMERLITE TT3 ASSAY, LAN.0003/1003/2003
K873858 · Amersham Corp. · Nov 1987
IMMUBEAD T3 ENZYME IMMUNOASSAY KIT
K872191 · Immunotech Corp. · Aug 1987
DELFIA(TM) TRIIODOTHYRONINE (T3) KIT
K864452 · Lkb Instruments, Inc. · Feb 1987
AMERLEX-M T3 RIA KIT FOR SERUM AND PLASMA
K860252 · Amersham Corp. · Feb 1986
TDX TOTAL T3
K851676 · Abbott Laboratories · May 1985